Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChesnara Regulatory News (CSN)

Share Price Information for Chesnara (CSN)

Share Price is delayed by 15 minutes
Get Live Data
317.50    0.50 (0.16%)
Bid:
315.50
Ask:
317.00
Spread: 1.50 (0.475%)
Market Cap: £732.37m
CSN Live PriceLast checked at - London Stock Exchange

Intraday Chesnara Share Chart

Result of AGM

17 May 2022 13:51

RNS Number : 8183L
Chesnara PLC
17 May 2022
 

 

LEI Number: 213800VFRMBRTSZ3SJ06

 

17 May 2022

 

CHESNARA plc

("Chesnara" or "the Company")

 

 

RESULT OF THE CHESNARA PLC 2022 ANNUAL GENERAL MEETING

 

Chesnara plc announces that the resolutions proposed at its Annual General Meeting held on 17 May 2022 were passed by a show of hands. For information, the results of the AGM, which includes the total number of votes received for each resolution, are set out below. The Company's issued share capital on 17 May 2022 consisted of 150,157,451 ordinary 5p shares and the number of voting rights was also 150,157,451 ordinary 5p shares (as there were no treasury shares).

 

No.

Resolution

No. of votes 'for' & 'discretionary'

%

Votes 'against'*

%

Total No. of votes cast

Votes 'withheld'

1

To receive and adopt the report and accounts for the year ended 31 December 2021

95,706,161

99.99

9,059

0.01

95,715,220

45,837

2

To approve the Directors' Remuneration Report

93,267,407

97.43

2,459,491

2.57

95,726,898

34,159

3

To declare a final dividend of 14.72p per ordinary share

95,751,262

99.99

3,731

0.01

95,754,993

6,064

4

To elect Steve Murray as a director

95,716,530

99.99

6,459

0.01

95,722,989

38,068

5

To elect Carol Hagh as a director

95,706,467

99.98

16,522

0.02

95,722,989

38,068

6

To elect Karin Bergstein as a director

95,707,702

99.98

15,287

0.02

95,722,989

38,068

7

To re-elect David Rimmington as a director

95,705,170

99.98

17,819

0.02

95,722,989

38,068

8

To re-elect Jane Dale as a director

95,230,992

99.49

491,997

0.51

95,722,989

38,068

9

To re-elect Luke Savage as a director

92,371,126

96.50

3,351,863

3.50

95,722,989

38,068

10

To re-elect Mark Hesketh as a director

95,055,357

99.30

667,632

0.70

95,722,989

38,068

11

To re-elect Eamonn Flanagan as a director

94,676,826

98.91

1,046,163

1.09

95,722,989

38,068

12

To re-appoint Deloitte LLP as auditor

95,701,658

99.96

38,589

0.04

95,740,247

20,810

13

To authorise the directors to determine the auditor's remuneration

95,710,436

99.97

31,991

0.03

95,742,427

18,630

14

To provide limited authority to make political donations and to incur political expenditure

94,182,354

98.37

1,564,775

1.63

95,747,129

13,928

15

To implement and operate a Savings Related Share Option Scheme

95,289,000

99.52

462,992

0.48

95,751,992

9,065

16

To authorise the directors to allot equity securities up to a specified amount

93,080,336

97.21

2,672,553

2.79

95,752,889

8,168

17

Special resolution - to give the directors power to allot equity securities for cash without making an offer to shareholders (rights issue or open offer)

94,562,055

98.76

1,190,834

1.24

95,752,889

8,168

18.

Special resolution - to give the directors power to allot equity securities for cash without making an offer to shareholders (financing or refinancing an acquisition)

93,056,973

97.18

2,695,916

2.82

95,752,889

8,168

19.

Special resolution - to give the Company limited authority to purchase its own shares

95,707,674

99.96

38,963

0.04

95,746,637

14,420

20.

Special resolution - to allow the Company to call general meetings on not less than 14 clear working days' notice

95,094,585

99.31

659,881

0.69

95,754,466

6,591

*Votes 'withheld' have not been included in the calculation of whether the resolution is carried. Percentages have been rounded to two decimal places.

 

The full text of the resolutions can be found in the Notice of the Meeting set out in the Financial Statements for the year ended 31 December 2021, copies of which are available on the Company's website, www.chesnara.co.uk. In accordance with Listing Rule 9.6.3, full details of the resolutions passed as special business will be submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism .

 

 

 

Investor Enquiries

Sam Perowne

Head of Strategic Development & Investor Relations

Chesnara plc

E - sam.perowne@chesnara.co.uk

 

Media Enquiries

Roddy Watt

Director, Capital Markets

FWD

T - 020 7280 0651 / 07714 770 493 

E - roddy.watt@fwdconsulting.co.uk

 

 

Notes to Editors

Chesnara is a European life and pensions consolidator listed on the London Stock Exchange. It administers approximately one million policies and operates as Countrywide Assured and Sanlam Life & Pensions in the UK, as The Waard Group and Scildon in the Netherlands, and as Movestic in Sweden.

 

Following a three pillar strategy, Chesnara's primary responsibility is the efficient administration of its customers' life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests. It also adds value by writing profitable new business in Sweden and the Netherlands and by undertaking value-adding acquisitions of either companies or portfolios.

 

Consistent delivery of the Company strategy has enabled Chesnara to increase its dividend for 17 years in succession.

 

Further details are available on the Company's website (www.chesnara.co.uk).

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGLDLFFLELZBBK
Date   Source Headline
1st Jun 20267:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
29th May 20267:00 amRNSDirector/PDMR Shareholding
27th May 20267:00 amRNSDirector/PDMR Shareholding
19th May 20267:00 amRNSDirector/PDMR Shareholding
14th May 20267:00 amRNSDirector/PDMR Shareholding
12th May 20262:00 pmRNSResult of AGM
1st May 20267:00 amRNSTotal Voting Rights
28th Apr 20267:00 amRNSDirector/PDMR Shareholding
17th Apr 20267:00 amRNSAdmission to Trading
10th Apr 20267:00 amRNSHolding(s) in Company
9th Apr 20267:00 amRNSNotice of AGM
1st Apr 20267:00 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSDirector/PDMR Shareholding
27th Mar 20263:40 pmRNSDirector/PDMR Shareholding
27th Mar 20267:00 amRNSDirector/PDMR Shareholding
26th Mar 20267:00 amRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSFinal Results
3rd Mar 20267:00 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSHolding(s) in Company
27th Feb 20267:00 amRNSUpdated Financial Framework and Notice of Results
17th Feb 20267:00 amRNSAcquisition
2nd Feb 20267:00 amRNSCompletion of HSBC Life (UK) Limited Acquisition
30th Jan 20262:00 pmRNSTotal Voting Rights
31st Dec 20257:00 amRNSTotal Voting Rights
31st Dec 20257:00 amRNSTotal Voting Rights
12th Dec 20251:45 pmRNSRegulatory Approval
12th Dec 20257:00 amRNSChange of Registered Office
9th Dec 20257:00 amRNSHolding(s) in Company
2nd Dec 20257:00 amRNSHolding(s) in Company
7th Nov 20257:00 amRNSTotal Voting Rights
30th Oct 20257:00 amRNSHolding(s) in Company
28th Oct 20257:00 amRNSBlock listing Interim Review
27th Oct 202512:04 pmRNSDirector/PDMR Shareholding
6th Oct 20257:00 amRNSTotal Voting Rights
28th Aug 20257:00 amRNSHalf-year Report
14th Aug 20257:00 amRNSNotice of Interim Results
13th Aug 20256:00 pmRNSPrimary Health Properties
30th Jul 20257:00 amRNS£150 MILLION RESTRICTED TIER 1 BOND ISSUE
28th Jul 20257:00 amRNSDirector/PDMR Shareholding
23rd Jul 202510:52 amRNSResult of Rump Placing
23rd Jul 20258:15 amRNSDirector/PDMR Shareholding
23rd Jul 20257:00 amRNSAnnouncement re: Rights Issue
8th Jul 20257:00 amRNSAdmission of Nil Paid Rights
3rd Jul 202512:10 pmRNSPublication of a Prospectus
3rd Jul 20257:00 amRNSAcquisition & Rights Issue
1st Jul 20257:00 amRNSTotal Voting Rights
17th Jun 20257:00 amRNSDirector/PDMR Shareholding
10th Jun 20257:00 amRNSDirector/PDMR Shareholding
6th Jun 20257:00 amRNSDirectorate Change
23rd May 20257:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.